440 related articles for article (PubMed ID: 15983290)
81. Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up.
Eveson DJ; Robinson TG; Potter JF
Am J Hypertens; 2007 Mar; 20(3):270-7. PubMed ID: 17324738
[TBL] [Abstract][Full Text] [Related]
82. Operational aspects of terminating the doxazosin arm of The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Pressel SL; Davis BR; Wright JT; Geraci TS; Kingry C; Ford CE; Piller LB; Bettencourt J; Kimmel B; Lusk C; Parks H; Simpson LM; Nwachuku C; Furberg CD;
Control Clin Trials; 2001 Feb; 22(1):29-41. PubMed ID: 11165421
[TBL] [Abstract][Full Text] [Related]
83. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.
Davis BR; Cutler JA; Gordon DJ; Furberg CD; Wright JT; Cushman WC; Grimm RH; LaRosa J; Whelton PK; Perry HM; Alderman MH; Ford CE; Oparil S; Francis C; Proschan M; Pressel S; Black HR; Hawkins CM
Am J Hypertens; 1996 Apr; 9(4 Pt 1):342-60. PubMed ID: 8722437
[TBL] [Abstract][Full Text] [Related]
84. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[TBL] [Abstract][Full Text] [Related]
85. Effects of Antihypertensive Class on Falls, Syncope, and Orthostatic Hypotension in Older Adults: The ALLHAT Trial.
Juraschek SP; Simpson LM; Davis BR; Beach JL; Ishak A; Mukamal KJ
Hypertension; 2019 Oct; 74(4):1033-1040. PubMed ID: 31476905
[TBL] [Abstract][Full Text] [Related]
86. A comparison between persistence to therapy in ALLHAT and in everyday clinical practice: a generalizability issue.
Cardinal H; Monfared AA; Dorais M; LeLorier J
Can J Cardiol; 2004 Mar; 20(4):417-21. PubMed ID: 15057318
[TBL] [Abstract][Full Text] [Related]
87. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD;
Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
[TBL] [Abstract][Full Text] [Related]
88. Choice of antihypertensive agent in isolated systolic hypertension and isolated diastolic hypertension: A secondary analysis of the ALLHAT trial.
Wang SY; Hanna JM; Gongal P; Onuma OK; Nanna MG
Am Heart J; 2022 Dec; 254():30-34. PubMed ID: 35932912
[TBL] [Abstract][Full Text] [Related]
89. Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study.
Barzilay JI; Davis BR; Bettencourt J; Margolis KL; Goff DC; Black H; Habib G; Ellsworth A; Force RW; Wiegmann T; Ciocon JO; Basile JN;
J Clin Hypertens (Greenwich); 2004 Mar; 6(3):116-25. PubMed ID: 15010644
[TBL] [Abstract][Full Text] [Related]
90. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
Lee HY; Kang HJ; Koo BK; Oh BH; Heung-Sun K; Kim KS; Seo HS; Ro YM; Kang JH; Woong CJ; Joo SJ; Kim MH; Joon-Han S; Yoon J; Park SH; Jin-Ok J; Ju AK; Chong-Yun R; Yeon KJ; Park KM; Lim DK; Park SY;
Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979
[TBL] [Abstract][Full Text] [Related]
91. Strengthening diuretics' role in hypertension.
Manag Care; 2010 Sep; 19(9):46. PubMed ID: 20931893
[No Abstract] [Full Text] [Related]
92. Risk of diabetes in a real-world setting among patients initiating antihypertensive therapy with valsartan or amlodipine.
Weycker D; Edelsberg J; Vincze G; Kjeldsen SE; Jamerson K; Khan ZM; Oster G
J Hum Hypertens; 2007 May; 21(5):374-80. PubMed ID: 17314999
[TBL] [Abstract][Full Text] [Related]
93. Influence of Prevalent and Incident Atrial Fibrillation on Post-Trial Major Events in ALLHAT.
Haywood LJ; Davis BR; Piller LB; Cushman WC; Cutler JA; Ford CE; Simpson LM; Ghosh A; Soliman EZ; Wright JT;
J Natl Med Assoc; 2017 Autumn; 109(3):172-181. PubMed ID: 28987246
[TBL] [Abstract][Full Text] [Related]
94. Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial.
Aksnes TA; Kjeldsen SE; Rostrup M; Störset O; Hua TA; Julius S
J Hum Hypertens; 2008 Aug; 22(8):520-7. PubMed ID: 18509347
[TBL] [Abstract][Full Text] [Related]
95. Prevention of Heart Failure in Hypertension-Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study.
Johnson K; Oparil S; Davis BR; Tereshchenko LG
J Am Heart Assoc; 2019 Apr; 8(8):e011961. PubMed ID: 30943832
[TBL] [Abstract][Full Text] [Related]
96. Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
Aksnes TA; Reims HM; Guptha S; Moan A; Os I; Kjeldsen SE
J Hum Hypertens; 2006 Nov; 20(11):860-6. PubMed ID: 16988754
[TBL] [Abstract][Full Text] [Related]
97. ADVANCE: action in diabetes and vascular disease.
Patel A; Chalmers J; Poulter N
J Hum Hypertens; 2005 Jun; 19 Suppl 1():S27-32. PubMed ID: 16075030
[TBL] [Abstract][Full Text] [Related]
98. ACE inhibitors versus diuretics: ALLHAT versus ANBP2.
Doggrell SA
Expert Opin Pharmacother; 2003 May; 4(5):825-8. PubMed ID: 12740004
[TBL] [Abstract][Full Text] [Related]
99. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
[TBL] [Abstract][Full Text] [Related]
100. A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension.
Strasser RH; Puig JG; Farsang C; Croket M; Li J; van Ingen H
J Hum Hypertens; 2007 Oct; 21(10):780-7. PubMed ID: 17541390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
